The Leader in Neurological Research and Clinical Studies.

Our Doctors

The Center for Neurological Research is the largest and most experienced neurology research center in the region. Our physicians – skilled in dozens of specialties – work together to ensure quality care and successful clinical trials. 

In order to provide comprehensive care for our patients, the Neurological Research Center provides specialized care for the following neurological conditions. Multiple Sclerosis; Epilepsy; Alzheimer’s/Dementia; Movement Disorders; Sleep Disorders; Stroke; Neurodiagnostics.

Dr Thomas Banas MD MS Neurologist with a Specialty in Movement Disorders

Thomas M. Banas, M.D., M.S.

DIRECTOR OF RESEARCH / NEUROLOGIST / MOVEMENT DISORDERS

Dr. Banas received a Master of Biomedical Engineering degree with High Honors from Case Western Reserve University, Cleveland, and then pursued his medical degree from the University of Cincinnati. He completed his residency at the University of Cincinnati Medical Center and has since then participated in over 70 research studies. Dr. Banas is the Director of Research at Fort Wayne Neurological Center and is serving as an Assistant Professor of Clinical Medicine at Indiana Medical School. He has his MS in biomedical engineering from Case Western Reserve University and now serves on multiples boards, including the industrial relations committee of the AAN. Dr. Banas specializes in neurology with extensive experience in stroke, epilepsy, neuro rehabilitation with a special interest in spasticity and movement disorders.

Clinical Trials, Research:

2019:    UCB Biopharma SPRL – A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy.   Sub-Investigator 

2018:   Acadia Pharmaceuticals ACP-NIS-001 – An Observational Study on the Management of Parkinson’s Disease Psychosis in Actual Practice. Primary Investigator

2018:   F. Hoffmann- LaRoche – A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early (Prodromal to Mild) Alzheimer’s Disease.  Sub-Investigator

See more studies lead by Dr. Thomas Banas, MD.

Dr James Stevens MD FASM Neurologist with Sleep Disorder Specialty

James Stevens, M.D., F.A.A.N., F.A.S.M.

NEUROLOGIST / SLEEP DISORDERS

Dr. Stevens received his medical degree from the Indiana University School of Medicine, where he graduated at the top of his class, receiving AOA honors his junior year. He completed his neurology resident training at Indiana University where he was a multi-year recipient of the Alexander Ross Award for outstanding neurologic research. He currently serves as a Professor of Neurology for the IUSM and is serving as President of the American Academy of Neurology . In addition, Dr. Stevens has been recognized annually as one of the “Best Doctors in America”, and has been a recipient of the “Patient’s Choice Award” since 2008 for being one of the most outstanding physicians in the United States. He has publications in over 15 renowned medical journals and has participated in over 100 clinical trials and research studies. Dr. Stevens specializes in both common and rare sleep disorders, ranging from sleep apnea to idiopathic hypersomnia.

Clinical Trials, Research:

2018:   F. Hoffmann-La Roche Ltd WN29922 – A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in patients with Early Alzheimer’s Disease. Principal Investigator 

2018:   Balance Therapeutics BTD-001 IH202 – A Randomized, Placebo-Controlled, Double- Blind, Crossover Study of Oral BTD-001 in Adults with Idiopathic Hypersomnia. Principal Investigator  

2018:   Jazz Pharmaceuticals 15-006 – A Double-blind, Placebo-Controlled, Randomized Withdrawal Study of the Efficacy and Safety of JZP-258 in Subjects with Narcolepsy with Cataplexy. Principal Investigator 

See all studies lead by Dr. James Stevens, MD.

Dr Ajay Gupta MD Neurologist with a Multiple Sclerosis Specialty

Ajay Gupta, M.D.

NEUROLOGIST / MULTIPLE SCLEROSIS

Dr. Gupta received his medical training at MP Shah Medical College in Jamnagar, India. His residency in neurology was accomplished at the Medical College of Ohio, Toledo, Ohio. Dr. Gupta furthered his professional training after his residency by completing dual fellowships in electroencephalography/ epilepsy and in multiple sclerosis/ neurological immunology at the Medical College of Ohio and at the National Institute of Health in Bethesda, Maryland. He is the Director of the Multiple Sclerosis Institute of NE Indiana, a Clinical Associate Professor of Neurology at IUSM, and has been the principal investigator in over 42 clinical research trials, while also participating in an additional 18 neurological research trials. Dr. Gupta specializes in Multiple Sclerosis (MS), epilepsy, and electroencephalography.

Clinical Trials in Multiple Sclerosis: 

2014:  Novartis: CVAY736X2202 – a Randomized, partially blind, placebo-controlled, proof-of concept study to assess the effect of a single infusion of VAY736 on disease activity as measured by brain MRI scans in patients with relapsing-remitting multiple sclerosis. Principle Investigator

2012:  La-Roche:  WA21093 – A randomized, double-blind, double-dummy,parallel-group study to evaluate the efficacy and safety of ocrelizumab in comparison to Interferon Beta-1a (Rebif®) in patients with relapsing multiple sclerosis. Principle Investigator

2011:  GSK:  OMS112831 – A randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the MRI efficacy and safety of six months’ administration of Ofatumumab in subjects with relapsing-remitting multiple sclerosis. Principle Investigator

See all studies lead by Dr. Ajay Gupta, MD.

Dr Marlene Bultemeyer MD Neurologist Epilepsy Specialty

Marlene Bultemeyer, M.D.

NEUROLOGIST / EPILEPTOLOGIST

Dr. Bultemeyer received her medical degree from the Indiana University School of Medicine. She completed her neurology resident training at Indiana University Medical Center, where she also completed a Fellowship in Neurophysiology. She has received advanced training in Epilepsy and associated EEG testing protocols. Dr. Bultemeyer is an Assistant Professor for IUSM and serves as the Director of the Neurodiagnostics Department at Fort Wayne Neurological Center. She also is the Director of the Neurodiagnostics Department at Lutheran Hospital of Fort Wayne and was instrumental in the department achieving status as the only accredited EEG lab in the region. Her specialties include epilepsy and neurodiagnostics.

Clinical Trials, Research:

2019:  UCB Biopharma SPRL – EP0092 – A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy.  Primary Investigator

2018:  Eisai – E2007-G000-506 – A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients with Epilepsy.  Primary Investigator

2016:  Eli LILLY 17x-MC-LLCF – A Multicenter, Randomized, Double-blind, Placebo- Controlled, Phase 3 study for patients with mild Alzheimer’s disease.  Sub- Investigator

See all studies lead by Dr. Marlene Bultemeyer, MD.

Dr Andrea Haller MD Neurologist with Sleep Disorder Specialty

Andrea Haller, M.D.

NEUROLOGIST / SLEEP DISORDERS

Andrea Haller, MD is a board-certified neurologist and sleep specialist at the Fort Wayne Neurological Center in Indiana.  A graduate of Harvard College, Dr. Haller earned her medical degree with honors in 1997 at the University of California, San Francisco (UCSF).  After completing her neurology residency at UCSF, Dr. Haller entered private practice in Indianapolis, providing inpatient and outpatient care. She moved to Fort Wayne in 2014.   Dr. Haller has served as Medical Director of stroke services at multiple facilities since 2004, and currently serves as the Medical Director for the Comprehensive Stroke Service of Lutheran Hospital.  In addition to stroke, Dr. Haller has particular interests in headaches and sleep disorders. She has been published in several renowned medical journals and has participated in a number of clinical research trials.

Clinical Trials, Research:

2018: Jazz Pharmaceuticals – 15-006 – A Phase III Double-blind, Placebo-controlled Randomized Withdrawal Study of the Efficacy and Safety of JZP-258 in Subjects with Narcolepsy with Cataplexy, Sub-Investigator

2017: Flamel/Avadel – CLFT218-1501 – A Phase III Double-blind, Placebo controlled to assess the Efficacy and Safety of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy, Sub-Investigator

2016: Duke Clinical Research Institute “Aramis” Study, Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-World Anticoagulant Management Issues and Stroke. Principal Investigator.

See all studies lead by Dr. Andrea Haller, MD.

Dr Natalie Manalo MD Neurologist with Sleep Medicine Specialty

Natalie Manalo, M.D.

NEUROLOGIST / SLEEP MEDICINE

Dr. Natalie Manalo graduated from Tulane University in New Orleans, Louisiana State University School of Medicine in Shreveport and completed her residency at Northwestern University in Evanston, Illinois, where she also did a fellowship in sleep medicine. Dr. Manalo also completed a fellowship in autoimmune neurology at Harvard University. She has been published in several renowned journals and has presented at medical conventions in her specialty.

Dr. Manalo’s Ongoing Research:

Systematic Review. Use of commercially available sleep tracking devices in insomnia, currently underway: Mentor, Dr. Kelly Baron at Northwestern Memorial Hospital.

Prospective Clinical Trial: Light therapy for Multiple Sclerosis Fatigue, currently underway, Mentors, Dr.Farrah Mateen and Dr. Aleksander Videnovic at Massachusetts General Hospital.

Madhav H. Bhat, M.D.

NEUROLOGIST / NEUROREHABILITATION / GENERAL ADULT NEUROLOGY

Dr. Bhat received his M.D. from the University of Bombay, Bombay, India. He completed residencies at St. Louis University, St. Louis, MO, and BYL Nair Hospital, Bombay, India, and at Hurley Medical Center, Flint, MI. He specializes in neurology and neuro-rehabilitation.

About Us - The Team at the Neurological Research Center

WANT TO WORK WITH US?

We are actively seeking talented neurologists to join our team.